Skip to main content
RSC Advances logoLink to RSC Advances
. 2022 Dec 23;13(1):720. doi: 10.1039/d2ra90131e

Correction: Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)

Ritika Sharma 1, Anchala Kumari 2, Bishwajit Kundu 3, Abhinav Grover 1,✉
PMCID: PMC9782849  PMID: 36605666

Abstract

Correction for ‘Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)’ by Ritika Sharma et al., RSC Adv., 2022, 12, 29469–29481, https://doi.org/10.1039/D2RA05061G.


In the original article, in Section 4.11 REMD simulations, the number of replicas, their average exchange probability and the temperature range utilized were inaccurately reported as 32, 20% and 290–500 K, respectively. However, the presented results were obtained using 48 replicas, with an average exchange probability of 13% and a temperature range of 298–380 K. The authors regret this error. The scientific conclusions of this article remain unchanged.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Supplementary Material


Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES